Generic drug maker Ozon Pharmaceuticals announced the IPO price range and trading start date.

Investors will be offered shares issued as part of the company’s additional issuance. There is also a stabilization mechanism of up to 15% of the IPO amount, which will be valid for 30 days after the start of trading.

The placement price will be set by the board of directors of Ozon Pharmaceuticals based on the results of the collection of applications, which will begin on October 11 and end on the 16th of the same month. Trading in the company’s shares on the Moscow Stock Exchange will begin on October 17 under the symbol OZPH.

The IPO will be available to Russian institutional, qualified and unqualified investors. The money raised will be used for the development of the company, reducing its debt load and other general corporate objectives, according to the press release.

The generic drug maker announced plans to list on the Moscow Stock Exchange on October 8. In April, Vedomosti sources reported that the company could raise more than 10 billion rubles.

• Ozon Pharmaceuticals was founded in 2001 in Zhigulevsk, Samara region. The company has no relationship with the Ozon market. According to the manufacturer’s own data, its portfolio includes more than 500 names of patented generic analogues.

• In the first six months of 2024, the company’s revenue amounted to 12.6 billion rubles, and net profit – 2.9 billion rubles.